n–3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer

Over the last decades a renewed interest in n−3 very long polyunsaturated fatty acids (PUFAs), derived mainly from fish oils in the human diet, has been observed because of their potential effects against cancer diseases, including breast carcinoma. These n−3 PUFAs mainly consist of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that, alone or in combination with anticancer agents, induce cell cycle arrest, autophagy, apoptosis, and tumor growth inhibition. A large number of molecular targets of n−3 PUFAs have been identified and multiple mechanisms appear to underlie their antineoplastic activities. Evidence exists that EPA and DHA also elicit anticancer effects by the conversion to their corresponding ethanolamide derivatives in cancer cells, by binding and activation of different receptors and distinct signaling pathways. Other conjugates with serotonin or dopamine have been found to exert anti-inflammatory activities in breast tumor microenvironment, indicating the importance of these compounds as modulators of tumor epithelial/stroma interplay. The objective of this review is to provide a general overview and an update of the current n−3 PUFA derivative research and to highlight intriguing aspects of the potential therapeutic benefits of these low-toxicity compounds in breast cancer treatment and care.

[1]  M. Cascio,et al.  Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion. , 2020, Prostaglandins, leukotrienes, and essential fatty acids.

[2]  Giuseppina Augimeri,et al.  Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer , 2020, Cells.

[3]  M. Johansson,et al.  Effects of Omega-3 Fatty Acids on Immune Cells , 2019, International journal of molecular sciences.

[4]  Giuseppina Augimeri,et al.  N-Eicosapentaenoyl Dopamine, A Conjugate of Dopamine and Eicosapentaenoic Acid (EPA), Exerts Anti-inflammatory Properties in Mouse and Human Macrophages , 2019, Nutrients.

[5]  A. Das,et al.  Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. , 2019, Prostaglandins & other lipid mediators.

[6]  R. Witkamp,et al.  The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation. , 2019, Prostaglandins & other lipid mediators.

[7]  K. Magalhães,et al.  Omega 3-DHA and Delta-Tocotrienol Modulate Lipid Droplet Biogenesis and Lipophagy in Breast Cancer Cells: The Impact in Cancer Aggressiveness , 2019, Nutrients.

[8]  Jyh‐cherng Yu,et al.  Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer , 2019, Journal of Experimental & Clinical Cancer Research.

[9]  P. Plastina,et al.  Capsaicin Analogues Derived from n-3 Polyunsaturated Fatty Acids (PUFAs) Reduce Inflammatory Activity of Macrophages and Stimulate Insulin Secretion by β-Cells In Vitro , 2019, Nutrients.

[10]  Stephen P. H. Alexander,et al.  n-3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[11]  M. Provencio,et al.  A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study , 2018, Clinical and Translational Oncology.

[12]  T. Rawling,et al.  Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives , 2018, Nanomaterials.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  J. Kopecka,et al.  ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy , 2017, International journal of molecular sciences.

[15]  Hassan Choucair,et al.  A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin To Promote Killing of Breast Cancer Cells. , 2017, Journal of medicinal chemistry.

[16]  R. Witkamp,et al.  Docosahexaenoyl serotonin emerges as most potent inhibitor of IL-17 and CCL-20 released by blood mononuclear cells from a series of N-acyl serotonins identified in human intestinal tissue. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[17]  A. Das,et al.  Anti-inflammatory ω-3 endocannabinoid epoxides , 2017, Proceedings of the National Academy of Sciences.

[18]  Shenglong Zhu,et al.  ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell lines , 2017, Scientific Reports.

[19]  P. Plastina,et al.  N-Docosahexaenoyl Dopamine, an Endocannabinoid-like Conjugate of Dopamine and the n-3 Fatty Acid Docosahexaenoic Acid, Attenuates Lipopolysaccharide-Induced Activation of Microglia and Macrophages via COX-2. , 2017, ACS chemical neuroscience.

[20]  G. Milne,et al.  Oxidative stress in relation to diet and physical activity among premenopausal women , 2016, British Journal of Nutrition.

[21]  R. Pieters,et al.  Docosahexaenoyl serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23-IL-17 signaling in macrophages. , 2016, Biochimica et biophysica acta.

[22]  C. Giordano,et al.  Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets. , 2016, Mini reviews in medicinal chemistry.

[23]  B. G. Sanders,et al.  Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP‐1 inhibition of Stat3 signaling , 2016, Molecular carcinogenesis.

[24]  M. Brentani,et al.  Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast Carcinoma Cells , 2015, BioMed research international.

[25]  C. Giordano,et al.  Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis. , 2015, Biochimica et biophysica acta.

[26]  Geir Bjorklund.  The Adjuvant Nutritional Intervention in Cancer (ANICA) Trial , 2015, Nutrition and cancer.

[27]  B. Kimler,et al.  Omega-3 fatty acids for breast cancer prevention and survivorship , 2015, Breast Cancer Research.

[28]  U. Das,et al.  Synergistic anti-tumor effects of melatonin and PUFAs from walnuts in a murine mammary adenocarcinoma model. , 2015, Nutrition.

[29]  J. Russo,et al.  Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells , 2015, In Vitro Cellular & Developmental Biology - Animal.

[30]  P. Plastina,et al.  Inhibition of COX‐2‐mediated eicosanoid production plays a major role in the anti‐inflammatory effects of the endocannabinoid N‐docosahexaenoylethanolamine (DHEA) in macrophages , 2015, British journal of pharmacology.

[31]  K. Weylandt,et al.  Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway[S] , 2014, Journal of Lipid Research.

[32]  Yueqing Gu,et al.  The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy , 2014, Oncotarget.

[33]  Thomas Hankemeier,et al.  A Protective Lipidomic Biosignature Associated with a Balanced Omega-6/Omega-3 Ratio in fat-1 Transgenic Mice , 2014, PloS one.

[34]  V. Davisson,et al.  Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells. , 2014, Bioorganic & medicinal chemistry.

[35]  J. Trygg,et al.  Individual Variation in Lipidomic Profiles of Healthy Subjects in Response to Omega-3 Fatty Acids , 2013, PloS one.

[36]  C. Giordano,et al.  Omega‐3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF‐7 breast cancer cells , 2013, Journal of cellular physiology.

[37]  R. Witkamp,et al.  N‐acyl amines of docosahexaenoic acid and other n–3 polyunsatured fatty acids – from fishy endocannabinoids to potential leads , 2013, British journal of pharmacology.

[38]  M. Brentani,et al.  Lipid raft disruption by docosahexaenoic acid induces apoptosis in transformed human mammary luminal epithelial cells harboring HER-2 overexpression. , 2013, The Journal of nutritional biochemistry.

[39]  P. Lewandowski,et al.  Marine polyunsaturated fatty acids and cancer therapy , 2013, British Journal of Cancer.

[40]  Haw‐Wen Chen,et al.  Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells , 2013, Archives of Toxicology.

[41]  A. D'Angelo,et al.  Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load. , 2012, Journal of clinical lipidology.

[42]  Q. Mei,et al.  In Vivo Anti-Tumor Activity of a New Doxorubicin Conjugate via α-Linolenic Acid , 2012, Bioscience, biotechnology, and biochemistry.

[43]  Weiqin Jiang,et al.  Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids. , 2012, Cancer research.

[44]  R. Tiwary,et al.  Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells. , 2012, Molecular nutrition & food research.

[45]  S. Bijlsma,et al.  Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues , 2012, Metabolomics.

[46]  S. Kersten,et al.  Mechanisms of gene regulation by fatty acids. , 2012, Advances in nutrition.

[47]  M. Cascio,et al.  Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[48]  Hee-Yong Kim,et al.  A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. , 2011, Prostaglandins & other lipid mediators.

[49]  R. Siddiqui,et al.  Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. , 2011, BioFactors.

[50]  K. Verhoeckx,et al.  Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract. , 2011, Biochimica et biophysica acta.

[51]  S. Catalano,et al.  Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells , 2011, Cell cycle.

[52]  D. Irimia,et al.  Decoding Functional Metabolomics with Docosahexaenoyl Ethanolamide (DHEA) Identifies Novel Bioactive Signals* , 2011, The Journal of Biological Chemistry.

[53]  D. Lovinger,et al.  N-Docosahexaenoylethanolamide promotes development of hippocampal neurons. , 2011, The Biochemical journal.

[54]  H. Chung,et al.  Evaluation of endogenous fatty acid amides and their synthetic analogues as potential anti-inflammatory leads. , 2011, Bioorganic & medicinal chemistry.

[55]  P. Plastina,et al.  The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264.7 macrophages: evidence for a new link between fish oil and inflammation , 2011, British Journal of Nutrition.

[56]  Dale L Boger,et al.  Fatty acid amide signaling molecules. , 2010, Bioorganic & medicinal chemistry letters.

[57]  P. Plastina,et al.  Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. , 2010, Biochimica et biophysica acta.

[58]  R. Vandenberg,et al.  N‐Acyl amino acids and N‐acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets , 2010, British journal of pharmacology.

[59]  K. Erickson,et al.  Fatty acids and breast cancer: the role of stem cells. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[60]  V. Davisson,et al.  Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells. , 2010, Bioorganic & medicinal chemistry.

[61]  V. Blanckaert,et al.  Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. , 2010, International journal of oncology.

[62]  S. Fuqua,et al.  Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. , 2009, The American journal of pathology.

[63]  P. Plastina,et al.  Selective Synthesis of Unsaturated N-Acylethanolamines by Lipase- Catalyzed N-Acylation of Ethanolamine with Unsaturated Fatty Acids , 2009 .

[64]  M. Metcalfe,et al.  The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. , 2009, European journal of cancer.

[65]  M. Nagarkatti,et al.  Endocannabinoids and immune regulation. , 2009, Pharmacological research.

[66]  K. Effenberger,et al.  Effects of Thymoquinone–Fatty Acid Conjugates on Cancer Cells , 2009, ChemMedChem.

[67]  Q. Mei,et al.  Conjugation with alpha-linolenic acid improves cancer cell uptake and cytotoxicity of doxorubicin. , 2009, Bioorganic & medicinal chemistry letters.

[68]  A. Heller,et al.  Anticancer actions of omega-3 fatty acids--current state and future perspectives. , 2009, Anti-cancer agents in medicinal chemistry.

[69]  S. Serini,et al.  Antineoplastic Effects of N-3 Polyunsaturated Fatty Acids in Combination With Drugs and Radiotherapy: Preventive and Therapeutic Strategies , 2009, Nutrition and cancer.

[70]  S. Burstein,et al.  Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation , 2009, The AAPS Journal.

[71]  S. Catalano,et al.  Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells , 2009, Breast Cancer Research and Treatment.

[72]  L. Petrocellis,et al.  The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats , 2008, Neuropharmacology.

[73]  K. Kairemo,et al.  Fatty acid facts, part II: role in the prevention of carcinogenesis, or, more fish on the dish? , 2008, Drug news & perspectives.

[74]  Emma K. Farrell,et al.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides. , 2008, Drug discovery today.

[75]  S. Pattingre,et al.  JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. , 2008, Molecular cell.

[76]  T. Bisogno.  Endogenous Cannabinoids: Structure and Metabolism , 2008, Journal of neuroendocrinology.

[77]  Christian Skonberg,et al.  Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. , 2008, Biochimica et biophysica acta.

[78]  Osman A. B. S. M. Gani.  Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists? , 2008, Cardiovascular diabetology.

[79]  Stephen P. H. Alexander,et al.  The complications of promiscuity: endocannabinoid action and metabolism , 2007, British journal of pharmacology.

[80]  T. Bisogno,et al.  Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. , 2007, Chemistry & biology.

[81]  T. Mikkelsen,et al.  A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals* , 2006, Journal of Biological Chemistry.

[82]  S. Catalano,et al.  Peroxisome Proliferator-Activated Receptor-γ Activates p53 Gene Promoter Binding to the Nuclear Factor-κB Sequence in Human MCF7 Breast Cancer Cells , 2006 .

[83]  A. A. Lyzhin,et al.  Antioxidant and neuroprotective properties of N-docosahexaenoyl dopamine , 2006, Bulletin of Experimental Biology and Medicine.

[84]  Philippe Bougnoux,et al.  CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. , 2006, The international journal of biochemistry & cell biology.

[85]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[86]  C. Jolly.  Diet manipulation and prevention of aging, cancer and autoimmune disease , 2005, Current opinion in clinical nutrition and metabolic care.

[87]  W. Stillwell,et al.  Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells , 2005, Breast Cancer Research.

[88]  S. O’Rahilly,et al.  The Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation , 2003 .

[89]  T. Bisogno,et al.  Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[90]  T. Bisogno,et al.  Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine. , 2001, Bioorganic & medicinal chemistry letters.

[91]  L. Petrocellis,et al.  N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. , 2000, The Biochemical journal.

[92]  M. Mason,et al.  The Effect of Fatty Acids and Analogues upon Intracellular Levels of Doxorubicin in Cells Displaying P-Glycoprotein Mediated Multidrug Resistance , 2000, Journal of drug targeting.

[93]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[94]  M. Willingham,et al.  Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. , 1999, Carcinogenesis.

[95]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[96]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[97]  J. Kopecka,et al.  OMEGA-3 LONG CHAIN POLYUNSATURATED FATTY ACIDS AS SENSITIZING 2 AGENTS AND MULTIDRUG RESISTANCE REVERTANTS IN CANCER THERAPY , 2017 .

[98]  U. Das,et al.  Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and Endocannabinoid System in Two Human Cancer Lines. , 2017, Archives of medical research.

[99]  William R Arnold,et al.  Endocannabinoid metabolism by cytochrome P450 monooxygenases. , 2015, Prostaglandins & other lipid mediators.

[100]  Y. Surh,et al.  Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation. , 2015, Life sciences.

[101]  P. Flachs,et al.  Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. , 2009, Clinical science.

[102]  S. Catalano,et al.  Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells. , 2006, Molecular endocrinology.

[103]  J. Lehmann,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.